Asian CEOs Feel the Heat of US-China Tech Restrictions in 2026
Asian CEOs are twice as concerned about tech export controls as US CEOs in 2026. A Conference Board survey highlights supply chain disruption as a top global risk.
Asian firms are feeling the impact of technology restrictions imposed by the United States and China far more acutely than their American counterparts. According to a recent survey by The Conference Board, supplier diversification has jumped to the top of the agenda as geopolitical tensions rewire global trade.
The Growing Gap in Geopolitical Anxiety
The divide is stark: 23% of Asian CEOs cited export controls as a primary trade concern, while only 11% of American leaders felt the same pressure. Max Zenglein, author of the report, noted that Asian firms sit at the absolute center of global tech manufacturing, making them the first to bleed when critical inputs are restricted.
Supply Chain Vulnerabilities Persist into 2026
Globally, the anxiety isn't limited to tech. The survey, which polled 771 CEOs among 1,732 executives, found that 41.6% of leaders are most concerned about supply chain disruptions. This reflects lingering scars from recent years as challenges mount across North America, Europe, and Asia.
Firms sit at the center of global tech manufacturing and supply chains, making them directly exposed to restrictions on critical inputs.
Beijing's recent investigation into Meta Platforms' acquisition of AI startup Manus and tensions over Nvidia’s H200 chips signal that China is building its own 'small yard, high fence' strategy. In response, CEOs are prioritizing operational agility through inventory optimization.
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
China is achieving significant milestones in its 'China agricultural seed self-reliance 2026' initiative, replacing foreign genetics with domestic varieties.
China has emerged as a credible challenger to the US in the China AI drug discovery competition, leveraging genomic data and clinical trial mining prowess.
The China Institute of Atomic Energy unveiled the POWER-750H, a high-energy hydrogen ion implanter aimed at breaking domestic chipmaking bottlenecks.
The Trump administration will seek separate semiconductor tariff agreements for individual countries. This bilateral strategy aims to reshape global tech trade and maximize U.S. leverage.
China is achieving significant milestones in its 'China agricultural seed self-reliance 2026' initiative, replacing foreign genetics with domestic varieties.
China has emerged as a credible challenger to the US in the China AI drug discovery competition, leveraging genomic data and clinical trial mining prowess.
The China Institute of Atomic Energy unveiled the POWER-750H, a high-energy hydrogen ion implanter aimed at breaking domestic chipmaking bottlenecks.
The Trump administration will seek separate semiconductor tariff agreements for individual countries. This bilateral strategy aims to reshape global tech trade and maximize U.S. leverage.